Fulgent Genetics (FLGT) Share-based Compensation Growth (5y) (2020 - 2026)
Fulgent Genetics (FLGT) Share-based Compensation Growth (5y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Fulgent Genetics | 518.37 Mn | 261.34 Mn | 25.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.59% |
| Mar 31, 2026 | 27.27% |
| Dec 31, 2025 | -17.33% |
| Sep 30, 2025 | -21.94% |
| Jun 30, 2025 | -57.53% |
| Mar 31, 2025 | 62.75% |
| Dec 31, 2024 | 89.37% |
| Sep 30, 2024 | 150.82% |
| Jun 30, 2024 | 73.64% |
| Mar 31, 2024 | 23.60% |
| Dec 31, 2023 | 80.42% |
| Sep 30, 2023 | 79.32% |
| Jun 30, 2023 | 78.29% |
| Mar 31, 2023 | 9.78% |
| Dec 31, 2022 | 121.80% |
| Sep 30, 2022 | 74.85% |
| Jun 30, 2022 | 80.08% |
| Mar 31, 2022 | 58.30% |
| Dec 31, 2021 | -38.64% |
| Sep 30, 2021 | 11.90% |